Linagliptin
-
Catalog number2240-50
-
PricePlease ask
-
Size50 mg
-
-
Alternative_name8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3- methyl-1--[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione; BI-1356
-
DescriptionAn antidiabetic agent. Acts as a potent inhibitor of dipeptidyl peptidase IV (DPP IV), an enzyme that breaks down glucagon-like peptide 1 (GLP-1). Prevents the inactivation of endogenous GLP-1 and GIP through competitive inhibition of the DPP IV enzyme.
-
CAS Number668270-12-0
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₅H₂₆N₈O₂
-
Molecular Weight472.54
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>15 mg/ml) or H₂O (
-
HandlingProtect from light and moisture
-
Tag LineA potent dipeptidyl peptidase IV (DPP IV) inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD14635356
-
PubChem CID10096344
-
SMILESCC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C
-
InChiInChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1
-
InChi KeyLTXREWYXXSTFRX-QGZVFWFLSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameLinagliptin
-
Alternative nameLinagliptin
-